CN Stock MarketDetailed Quotes
301060 Shanghai Labway Clinical Laboratory
- 9.98
- -0.67-6.29%
Market Closed Nov 22 15:00 CST
4.00BMarket Cap-22030P/E (TTM)
10.69High9.96Low86.13KlotVolume10.69Open10.65Pre Close88.47MTurnover2.42%Turnover RatioLossP/E (Static)400.52MShares15.2752wk High2.31P/B3.56BFloat Cap7.3452wk Low12.78Limit Up356.58MShs Float60.60Historical High8.52Limit Down6.85%Amplitude7.34Historical Low--Dividend TTM10.27Avg Price51.48KlotAsk--Div YieldTTM100Lot Size32.13KlotBid
Shanghai Labway Clinical Laboratory Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -34.67%1.4B | -34.54%903.1M | -35.51%420.45M | 2.78%2.89B | 34.05%2.14B | 61.43%1.38B | 64.54%651.93M | 107.93%2.81B | 60.86%1.6B | 37.60%854.58M |
| Refunds of taxes and levies | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Cash received relating to other operating activities | -36.95%21.19M | -60.11%10.7M | -72.14%5.6M | -9.17%40.2M | 58.97%33.61M | 103.15%26.82M | 365.83%20.09M | 83.79%44.26M | 36.30%21.14M | 17.35%13.2M |
| Cash inflows from operating activities | -34.71%1.42B | -35.03%913.8M | -36.60%426.04M | 2.60%2.93B | 34.37%2.17B | 62.07%1.41B | 67.78%672.02M | 107.51%2.85B | 60.48%1.62B | 37.24%867.79M |
| Goods services cash paid | -15.77%1.09B | -3.52%741.42M | -3.29%343.75M | -8.81%1.64B | 23.63%1.3B | 16.76%768.46M | 0.92%355.46M | 157.07%1.8B | 44.60%1.05B | 47.50%658.13M |
| Staff behalf paid | -45.89%198.64M | -53.25%140.53M | -58.66%69.04M | -18.10%461.84M | -30.64%367.07M | -0.42%300.62M | 44.15%167.03M | 128.66%563.93M | 225.20%529.26M | 164.50%301.9M |
| All taxes paid | -61.64%37.79M | -65.22%31.21M | -49.60%17.93M | -37.42%121.5M | -29.76%98.49M | 11.68%89.75M | 13.16%35.58M | 151.33%194.14M | 152.48%140.23M | 104.30%80.36M |
| Cash paid relating to other operating activities | -23.76%116.64M | -55.25%48.77M | -34.78%34.06M | -26.04%157.42M | 7.58%153M | 9.52%108.99M | -1.74%52.23M | 66.07%212.84M | 23.09%142.22M | 128.86%99.52M |
| Cash outflows from operating activities | -24.52%1.45B | -24.13%961.94M | -23.84%464.78M | -14.03%2.38B | 2.97%1.92B | 11.22%1.27B | 10.42%610.29M | 140.47%2.77B | 75.62%1.86B | 77.24%1.14B |
| Net cash flows from operating activities | -111.05%-28.27M | -134.74%-48.14M | -162.75%-38.74M | 549.88%546.99M | 204.48%255.9M | 150.93%138.58M | 140.57%61.73M | -62.34%84.17M | -366.01%-244.93M | -2,413.04%-272.12M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 259.18%170M | 1,809.96%140M | 533.30%50M | -64.72%247.36M | -93.25%47.33M | -98.95%7.33M | -97.85%7.9M | 8.86%701.15M | 276.96%701.15M | 775.34%701.15M |
| Cash received from returns on investments | 219.61%576.16K | 697.07%439.32K | 69.56%167.67K | -94.12%559.34K | -98.11%180.27K | -99.42%55.12K | -97.56%98.89K | 38.27%9.51M | 47.45%9.51M | 148.38%9.51M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 1,313.48%3.08M | 1,482.87%3M | 111.29%28K | -14.65%3.99M | -88.98%217.61K | -82.91%189.31K | -98.03%13.25K | -14.85%4.68M | 150.07%1.97M | -35.80%1.11M |
| Net cash received from disposal of subsidiaries and other business units | --3.6M | --2.3M | --0 | --0 | ---- | --0 | --0 | --1.92K | ---- | --0 |
| Cash received relating to other investing activities | ---- | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 |
| Cash inflows from investing activities | 271.38%177.25M | 1,824.03%145.73M | 526.88%50.2M | -64.78%251.91M | -93.30%47.73M | -98.94%7.57M | -97.85%8.01M | 8.97%715.34M | 268.78%712.64M | 730.99%711.76M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -85.31%51.76M | 11.62%35.85M | 29.44%17.65M | 73.37%398.89M | 90.38%352.24M | -71.95%32.12M | -62.13%13.64M | 93.53%230.08M | 581.89%185.02M | 236.29%114.51M |
| Cash paid to acquire investments | 24.29%174M | --144M | --50M | -21.23%240.42M | -53.94%140M | --0 | ---- | -67.56%305.21M | 7.35%303.96M | 11.04%285.96M |
| Net cash paid to acquire subsidiaries and other business units | ---- | --0 | --0 | --11.1M | --11.1M | --11.1M | --11.1M | --0 | ---- | --0 |
| Cash paid relating to other investing activities | ---- | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 |
| Cash outflows from investing activities | -55.15%225.76M | 316.12%179.85M | 173.46%67.65M | 21.51%650.41M | 2.94%503.34M | -89.21%43.22M | -92.36%24.74M | -49.50%535.29M | 57.59%488.99M | 37.35%400.47M |
| Net cash flows from investing activities | 89.35%-48.5M | 4.29%-34.12M | -4.33%-17.46M | -321.32%-398.5M | -303.72%-455.61M | -111.45%-35.65M | -134.86%-16.73M | 144.63%180.05M | 291.09%223.65M | 251.17%311.29M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -53.44%3.48M | -48.94%3M | 200.00%3M | -18.25%9.23M | 97.49%7.48M | 229.13%5.88M | 27.39%1M | -93.23%11.29M | -97.69%3.79M | -64.86%1.79M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -53.44%3.48M | -48.94%3M | 200.00%3M | -18.25%9.23M | 97.49%7.48M | 229.13%5.88M | 27.39%1M | 37.74%11.29M | -25.49%3.79M | -64.86%1.79M |
| Cash from borrowing | -65.76%122.93M | -28.02%112.93M | -87.46%2.5M | 86.17%368.64M | 138.22%359.07M | 38.85%156.9M | 895.00%19.9M | 4,851.24%198.01M | 3,668.97%150.73M | 4,972.29%113M |
| Cash received relating to other financing activities | ---- | --0 | --0 | -87.22%510K | -86.72%510K | --510K | --0 | --3.99M | --3.84M | --0 |
| Cash inflows from financing activities | -65.56%126.41M | -29.00%115.93M | -73.71%5.5M | 77.40%378.37M | 131.79%367.06M | 42.25%163.29M | 650.45%20.9M | 24.92%213.29M | -5.53%158.36M | 1,470.72%114.79M |
| Borrowing repayment | 44.61%186.4M | 34.28%138.9M | 118.06%7.5M | 837.00%168.65M | 616.14%128.9M | 5,073.94%103.44M | 72.04%3.44M | 799.96%18M | 799.96%18M | -0.04%2M |
| Dividend interest payment | -85.41%19.63M | -77.45%14.06M | 230.07%4M | 8.83%136.71M | 8.73%134.59M | -48.44%62.35M | 7,452.01%1.21M | 810.07%125.61M | 257,020.28%123.79M | 7,431.11%120.93M |
| -Including:Cash payments for dividends or profit to minority shareholders | 52.38%12.5M | --0 | --0 | --0 | --8.2M | --4.6M | --0 | --0 | ---- | --0 |
| Cash payments relating to other financing activities | 46.75%19.88M | 71.66%17.17M | 64.79%8.14M | 47.38%28.28M | -12.91%13.55M | -6.78%10M | 20.87%4.94M | -45.46%19.19M | --15.56M | 5.30%10.73M |
| Cash outflows from financing activities | -18.45%225.91M | -3.22%170.13M | 104.77%19.64M | 104.94%333.64M | 76.07%277.04M | 31.52%175.79M | 57.17%9.59M | 219.29%162.8M | 7,582.17%157.34M | 868.81%133.66M |
| Net cash flows from financing activities | -210.53%-99.5M | -333.26%-54.2M | -225.06%-14.14M | -11.41%44.73M | 8,784.86%90.02M | 33.73%-12.51M | 440.97%11.31M | -57.84%50.48M | -99.39%1.01M | -190.91%-18.88M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -150.55%-365.61K | -6,413.45%-679.77K | -613.78%-165.53K | -2.42%-569.96K | 67.95%-145.92K | 94.55%-10.44K | 287.51%32.22K | -2,946.48%-556.49K | -3,457.20%-455.31K | -386.98%-191.48K |
| Net increase in cash and cash equivalents | -60.82%-176.65M | -251.67%-137.13M | -225.14%-70.5M | -38.68%192.65M | -430.17%-109.84M | 349.80%90.42M | 152.42%56.34M | 622.50%314.15M | -416.95%-20.72M | 109.01%20.1M |
| Add:Begin period cash and cash equivalents | 28.94%858.27M | 28.94%858.27M | 28.94%858.27M | 89.38%665.62M | 89.38%665.62M | 89.38%665.62M | 89.38%665.62M | -14.61%351.48M | -0.20%351.48M | -14.61%351.48M |
| End period cash equivalent | 22.64%681.62M | -4.62%721.14M | 9.11%787.77M | 28.94%858.27M | 68.03%555.78M | 103.47%756.04M | 195.89%721.97M | 89.38%665.62M | -5.00%330.76M | 97.20%371.58M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data